-
FDA generic user fees moving closer to reality
ROCKVILLE, Md. — A backlog of more than 2,000 drug entities and devices is awaiting approval. That’s the situation facing the Food and Drug Administration and the generic pharmaceutical industry—and it’s the chief impetus behind the FDA’s push to impose user fees on generic drug makers seeking the agency’s review and approval for their brand-equivalent medicines.
-
In victory for retail pharmacy, military levels TRICARE prescription purchasing field
ALEXANDRIA, Va. — In a ruling hailed by retail pharmacy leaders, the Department of Defense now is insisting that drug manufacturers extend the same discounts for prescription drugs sold at community pharmacies that the military gets for medicines dispensed through base dispensaries or mail order.